258 related articles for article (PubMed ID: 21546932)
1. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis.
Brown ML; Bonomi L; Ungerleider N; Zina J; Kimura F; Mukherjee A; Sidis Y; Schneyer A
Obesity (Silver Spring); 2011 Oct; 19(10):1940-9. PubMed ID: 21546932
[TBL] [Abstract][Full Text] [Related]
2. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults.
Mukherjee A; Sidis Y; Mahan A; Raher MJ; Xia Y; Rosen ED; Bloch KD; Thomas MK; Schneyer AL
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1348-53. PubMed ID: 17229845
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice.
Brandt C; Hansen RH; Hansen JB; Olsen CH; Galle P; Mandrup-Poulsen T; Gehl J; Pedersen BK; Hojman P
Metabolism; 2015 Feb; 64(2):283-95. PubMed ID: 25456456
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
5. Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity.
Bonomi L; Brown M; Ungerleider N; Muse M; Matzuk MM; Schneyer A
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E587-96. PubMed ID: 22739106
[TBL] [Abstract][Full Text] [Related]
6. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3.
Saito S; Sidis Y; Mukherjee A; Xia Y; Schneyer A
Endocrinology; 2005 Dec; 146(12):5052-62. PubMed ID: 16150905
[TBL] [Abstract][Full Text] [Related]
7. Activin Enhances α- to β-Cell Transdifferentiation as a Source For β-Cells In Male FSTL3 Knockout Mice.
Brown ML; Andrzejewski D; Burnside A; Schneyer AL
Endocrinology; 2016 Mar; 157(3):1043-54. PubMed ID: 26727106
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle.
Han X; Møller LLV; De Groote E; Bojsen-Møller KN; Davey J; Henríquez-Olguin C; Li Z; Knudsen JR; Jensen TE; Madsbad S; Gregorevic P; Richter EA; Sylow L
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1241-1257. PubMed ID: 31402604
[TBL] [Abstract][Full Text] [Related]
9. FSTL3-Neutralizing Antibodies Enhance Glucose-Responsive Insulin Secretion in Dysfunctional Male Mouse and Human Islets.
Brown ML; Lopez A; Meyer N; Richter A; Thompson TB
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 33539535
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.
Xia Y; Sidis Y; Schneyer A
Mol Endocrinol; 2004 Apr; 18(4):979-94. PubMed ID: 14739256
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 9 (GDF9) suppresses follistatin and follistatin-like 3 production in human granulosa-lutein cells.
Shi FT; Cheung AP; Huang HF; Leung PC
PLoS One; 2011; 6(8):e22866. PubMed ID: 21829661
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.
Smith KR; Hussain T; Karimian Azari E; Steiner JL; Ayala JE; Pratley RE; Kyriazis GA
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E688-E698. PubMed ID: 26884387
[TBL] [Abstract][Full Text] [Related]
13. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.
Ungerleider NA; Bonomi LM; Brown ML; Schneyer AL
Endocrinology; 2013 Jun; 154(6):2025-33. PubMed ID: 23533219
[TBL] [Abstract][Full Text] [Related]
14. Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.
Cash JN; Angerman EB; Keutmann HT; Thompson TB
Mol Endocrinol; 2012 Jul; 26(7):1167-78. PubMed ID: 22593183
[TBL] [Abstract][Full Text] [Related]
15. Heparin and activin-binding determinants in follistatin and FSTL3.
Sidis Y; Schneyer AL; Keutmann HT
Endocrinology; 2005 Jan; 146(1):130-6. PubMed ID: 15471966
[TBL] [Abstract][Full Text] [Related]
16. Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes.
Sylow L; Vind BF; Kruse R; Møller PM; Wojtaszewski JFP; Richter EA; Højlund K
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112102
[TBL] [Abstract][Full Text] [Related]
17. Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets.
Brown ML; Kimura F; Bonomi LM; Ungerleider NA; Schneyer AL
Islets; 2011; 3(6):367-75. PubMed ID: 21964310
[TBL] [Abstract][Full Text] [Related]
18. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
[TBL] [Abstract][Full Text] [Related]
19. Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance.
Palanivel R; Fullerton MD; Galic S; Honeyman J; Hewitt KA; Jorgensen SB; Steinberg GR
Diabetologia; 2012 Nov; 55(11):3083-93. PubMed ID: 22872213
[TBL] [Abstract][Full Text] [Related]
20. Follistatins in glucose regulation in healthy and obese individuals.
Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Tsilingiris D; Alexandrou A; Mantzoros CS
Diabetes Obes Metab; 2019 Mar; 21(3):683-690. PubMed ID: 30393997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
